Complexo Hospitalario Universitario de Ourense-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252

  2. Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy

    International Journal of Cancer, Vol. 154, Núm. 1, pp. 124-132

  3. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612

  4. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318

2023

  1. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis

    Gastroenterology, Vol. 165, Núm. 1, pp. 162-172.e5

  2. Germline mutations in WNK2 could be associated with serrated polyposis syndrome

    Journal of Medical Genetics, Vol. 60, Núm. 6, pp. 557-567

  3. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

2022

  1. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 6, pp. 440-449

  2. Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU

    Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058

  3. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 2

  4. Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

    Journal of Clinical Medicine, Vol. 11, Núm. 24

  5. Risk of Colorectal Cancer and Advanced Polyps One Year after Excision of High-Risk Adenomas

    Diseases of the Colon and Rectum, Vol. 65, Núm. 9, pp. 1112-1120

2021

  1. Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

    Molecular Diagnosis and Therapy, Vol. 25, Núm. 5, pp. 563-576

2020

  1. Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions

    Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3

  2. Impact of the faecal immunochemical test on colorectal cancer survival

    BMC Cancer, Vol. 20, Núm. 1

  3. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

2019

  1. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

2018

  1. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia

    United European Gastroenterology Journal, Vol. 6, Núm. 1, pp. 123-130

  2. Plasma miRNAs signature validation for early detection of colorectal cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106

  3. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

    Gastroenterologia y Hepatologia